Preemptive use of drugs improves Endodontic Treatment of symptomatic teeth

Not Applicable

• Conditions: Pulpitis; Pain; C07.793.237

• Registration Number: RBR-4y22q9z
• Lead Sponsor: Centro de Pesquisas Odontológicas São Leopoldo Mandic SS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-04-01
• Study Start: 2023-05-18
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Healthy patient (American Association of Anesthesiologists - class I); having lower molar diagnosed with irreversible symptomatic pulpitis; aged between 20 and 45 years; both genders; endodontic treatment performed within the interval between 80 and 90 minutes performed in patients who did not take any type of analgesic medication in the 12 hours preceding the endodontic treatment

Exclusion Criteria

Patients allergic or intolerant to diclofenacs, dexamethasone, articaine or any other drug/material used in this study; pregnant or lactating women; teeth with periodontal problems or radiographic images suggestive of internal/external resorptions; endodontic treatments not completed in a single session

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the effect of using preemptive oral medication with dexamethasone or diclofenac potassium on the success of inferior alveolar nerve block 15 minutes after anesthesia and its influence on postoperative pain intensity 6, 12, 24, 48 and 72 hours after the end of the endodontic procedure.

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected.